Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018)

Amneal Pharmaceuticals' (AMRX) quarterly FCF Payout Ratio came in at 1.32 in Q2 2018, down 133.2% quarter-over-quarter from 3.98 in Q1 2018.

Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018) Analysis & Trends

Amneal Pharmaceuticals' FCF Payout Ratio history runs 2 years deep, the most recent figure standing at 1.32 for Q2 2018.

On a quarterly basis, FCF Payout Ratio changed N/A year-over-year to 1.32 in Q2 2018; TTM through Mar 2019 was 4.61, a N/A change from a year earlier, with the FY2018 full-year figure at 1.09, down 59.32% from the prior year.
FCF Payout Ratio eased to 1.32 in Q2 2018 per AMRX's latest filing, from 3.98 in the prior quarter.
Across five years, FCF Payout Ratio topped out at 3.98 in Q1 2018 and bottomed at 1.32 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	0.77
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-10.50
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	0.40
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Amneal Pharmaceuticals	5.68 Bn	5.67 Bn	320.11 Mn	-

Download Data